176 related articles for article (PubMed ID: 32473242)
21. Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
Weng WH; Leung WH; Pang YJ; Hsu HH
Oncol Rep; 2016 Jan; 35(1):107-16. PubMed ID: 26496897
[TBL] [Abstract][Full Text] [Related]
22. Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth.
Jeoung MH; Kim TK; Kim JW; Cho YB; Na HJ; Yoo BC; Shim H; Song DK; Heo K; Lee S
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31683810
[TBL] [Abstract][Full Text] [Related]
23. Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Strepkos D; Markouli M; Klonou A; Papavassiliou AG; Piperi C
Cancer Res; 2021 Feb; 81(3):525-534. PubMed ID: 33115801
[TBL] [Abstract][Full Text] [Related]
24. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.
Torrano J; Al Emran A; Hammerlindl H; Schaider H
Clin Epigenetics; 2019 Mar; 11(1):43. PubMed ID: 30850015
[TBL] [Abstract][Full Text] [Related]
25. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
26. Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer.
Cao LL; Liu H; Yue Z; Liu L; Pei L; Gu J; Wang H; Jia M
Biometals; 2018 Oct; 31(5):797-805. PubMed ID: 29951879
[TBL] [Abstract][Full Text] [Related]
27. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
Di Nicolantonio F; Martini M; Molinari F; Sartore-Bianchi A; Arena S; Saletti P; De Dosso S; Mazzucchelli L; Frattini M; Siena S; Bardelli A
J Clin Oncol; 2008 Dec; 26(35):5705-12. PubMed ID: 19001320
[TBL] [Abstract][Full Text] [Related]
28. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
Rodriguez-Paredes M; Martinez de Paz A; Simó-Riudalbas L; Sayols S; Moutinho C; Moran S; Villanueva A; Vázquez-Cedeira M; Lazo PA; Carneiro F; Moura CS; Vieira J; Teixeira MR; Esteller M
Oncogene; 2014 May; 33(21):2807-13. PubMed ID: 23770855
[TBL] [Abstract][Full Text] [Related]
29. Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells.
Lee S; Lee C; Hwang CY; Kim D; Han Y; Hong SN; Kim SH; Cho KH
Mol Cancer Res; 2020 Jan; 18(1):118-129. PubMed ID: 31896605
[TBL] [Abstract][Full Text] [Related]
30. Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.
Bray SM; Lee J; Kim ST; Hur JY; Ebert PJ; Calley JN; Wulur IH; Gopalappa T; Wong SS; Qian HR; Ting JC; Liu J; Willard MD; Novosiadly RD; Park YS; Park JO; Lim HY; Kang WK; Aggarwal A; Kim HC; Reinhard C
Sci Rep; 2019 Oct; 9(1):15365. PubMed ID: 31653970
[TBL] [Abstract][Full Text] [Related]
31. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis.
Klonou A; Korkolopoulou P; Giannopoulou AI; Kanakoglou DS; Pampalou A; Gargalionis AN; Sarantis P; Mitsios A; Sgouros S; Papavassiliou AG; Piperi C
J Mol Med (Berl); 2023 Apr; 101(4):387-401. PubMed ID: 36811655
[TBL] [Abstract][Full Text] [Related]
32. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
33. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.
Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H
Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932
[TBL] [Abstract][Full Text] [Related]
35. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
36. SETDB1 promotes progression through upregulation of SF3B4 expression and regulates the immunity in ovarian cancer.
Yang H; Sui L; Cai C; Chu H; Diao Y
J Ovarian Res; 2024 Feb; 17(1):34. PubMed ID: 38317200
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status.
Kato J; Futamura M; Kanematsu M; Gaowa S; Mori R; Tanahashi T; Matsuhashi N; Yoshida K
Int J Cancer; 2016 Mar; 138(6):1516-27. PubMed ID: 26437179
[TBL] [Abstract][Full Text] [Related]
38. Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse.
Kim J; Zhao H; Dan J; Kim S; Hardikar S; Hollowell D; Lin K; Lu Y; Takata Y; Shen J; Chen T
PLoS Genet; 2016 Apr; 12(4):e1005970. PubMed ID: 27070551
[TBL] [Abstract][Full Text] [Related]
39. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling.
Chen LY; Zhi Z; Wang L; Zhao YY; Deng M; Liu YH; Qin Y; Tian MM; Liu Y; Shen T; Sun LN; Li JM
J Pathol; 2019 May; 248(1):103-115. PubMed ID: 30666650
[TBL] [Abstract][Full Text] [Related]
40. YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia†.
Guo M; Li X; Li T; Liu R; Pang W; Luo J; Zeng W; Zheng Y
Biol Reprod; 2024 Jan; 110(1):48-62. PubMed ID: 37812443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
